Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Toxicology

• Publication date

  2014-02-28

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.tox.2013.12.002PMID 24374136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presence and sources of anthropogenic perfluoroalkyl acids in high-consumption tap-water based beverages.

  2013cited by this paper
• Combined Effects of PFOS and PFOA on Zebrafish (Danio rerio) Embryos

  2013cited by this paper
• In vitro toxicological characterization of perfluorinated carboxylic acids with different carbon chain lengths.

  2013cited by this paper
• Determinants of maternal and fetal exposure and temporal trends of perfluorinated compounds

  2013cited by this paper
• Testing for departures from additivity in mixtures of perfluoroalkyl acids (PFAAs).

  2013cited by this paper
• Effect of Pregnancy on The Levels of Selected Perfluoroalkyl Compounds for Females Aged 17–39 Years: Data From National Health and Nutrition Examination Survey 2003–2008

  2013cited by this paper
• Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds.

  2012cited by this paper
• Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR.

  2012cited by this paper
• Dietary exposure to perfluoroalkyl acids for the Swedish population in 1999, 2005 and 2010.

  2012cited by this paper
• Toxicological interactions of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) with selected pollutants.

  2012cited by this paper
• Genomic biomarkers of phthalate-induced male reproductive developmental toxicity: a targeted RT-PCR array approach for defining relative potency.

  2012cited by this paper
• Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008.

  2011influential reference
• Widely Used Pesticides with Previously Unknown Endocrine Activity Revealed as in Vitro Antiandrogens

  2011cited by this paper
• Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.

  2011cited by this paper
• Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice.

  2011cited by this paper
• Perfluoroalkyl and Polyfluoroalkyl Substances in the Environment: Terminology, Classification, and Origins

  2011cited by this paper
• Hepatocellular hypertrophy and cell proliferation in Sprague–Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARα and CAR/PXR

  2010cited by this paper
• Developmental Effects of Perfluorononanoic Acid in the Mouse Are Dependent on Peroxisome Proliferator-Activated Receptor-Alpha

  2010cited by this paper
• Levels and trends of poly- and perfluorinated compounds in the arctic environment.

  2010cited by this paper
• Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects

  2010cited by this paper
• Modeling the interaction of binary and ternary mixtures of estradiol with bisphenol A and bisphenol AF in an in vitro estrogen-mediated transcriptional activation assay (T47D-KBluc).

  2010cited by this paper
• Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells

  2009cited by this paper
• Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures.

  2009cited by this paper
• Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse.

  2009cited by this paper
• Combined effects of polyfluorinated and perfluorinated compounds on primary cultured hepatocytes from rare minnow (Gobiocypris rarus) using toxicogenomic analysis.

  2009cited by this paper
• Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid.

  2009cited by this paper
• Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.

  2008cited by this paper
• Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.

  2008cited by this paper
• Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors.

  2008cited by this paper
• Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths.

  2008cited by this paper
• A review of independent action compared to concentration addition as reference models for mixtures of compounds with different molecular target sites

  2008cited by this paper
• Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha.

  2007cited by this paper
• Exposure of an adult population to perfluorinated substances using duplicate diet portions and biomonitoring data.

  2007cited by this paper
• Perfluoroalkyl acids: a review of monitoring and toxicological findings.

  2007cited by this paper
• Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses.

  2007cited by this paper
• Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000

  2007cited by this paper
• Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.

  2007cited by this paper
• Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague–Dawley rat. Birth Defects Research (Part B) 68:465–471, 2003.†

  2006cited by this paper
• Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha.

  2006cited by this paper
• Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors ( , / , ) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate

  2006cited by this paper
• Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.

  2006cited by this paper
• Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α

  2006cited by this paper
• An integrated addition and interaction model for assessing toxicity of chemical mixtures.

  2005cited by this paper
• Joint action of polycyclic aromatic hydrocarbons: predictive modeling of sublethal toxicity.

  2005cited by this paper
• Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.

  2004cited by this paper
• trans-Activation of PPARα and Induction of PPARα Target Genes by Perfluorooctane-Based Chemicals

  2004cited by this paper
• trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals.

  2004cited by this paper
• Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats.

  2003cited by this paper
• Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat.

  2003cited by this paper
• Effects of the environmental oestrogens bisphenol A, tetrachlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4,4'-dihydroxybiphenyl on oestrogen receptor binding, cell proliferation and regulation of oestrogen sensitive proteins in the human breast cancer cell line MCF-7.

  2003cited by this paper
• Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.

  2003cited by this paper
• Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys.

  2002cited by this paper
• Growing concern over perfluorinated chemicals.

  2001cited by this paper
• Analysis of Surfactants

  2000cited by this paper
• trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals.

  1999cited by this paper
• trans-activation of PPARα and PPARγ by structurally diverse environmental chemicals

  1999cited by this paper
• The search for synergy: a critical review from a response surface perspective.

  1995cited by this paper

• Air emissions during destruction of PFAS-containing materials

  2026cites this paper
• Embryotoxicity and mixture effects of legacy PFAS in a human iPSC-based 3D model

  2026cites this paper
• Enhanced spatial analysis assessing the association between PFAS-contaminated water and cancer incidence: rationale, study design, and methods

  2025cites this paper
• Perfluorooctane sulfonate (PFOS) exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model.

  2025cites this paper
• Extracellular Vesicle (EV) Mechanisms of Toxicity for Per and Polyfluoroalkyl Substances: Comparing Transcriptomic Points of Departure Across Global Versus EV Regulatory Gene Sets

  2025cites this paper
• Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis.

  2025cites this paper
• The carcinogenic mechanism of per- and polyfluoroalkyl substances on clear cell renal cell carcinoma: a combined study of network toxicology and virtual drug screening.

  2025cites this paper
• Forever Chemicals: An Exploratory, Population‐Based Analysis of Per‐ and Polyfluoroalkyl Substances Exposure and Effects on Sinonasal Health

  2025cites this paper
• Managing PFAS in Sewage Sludge: Exposure Pathways, Impacts, and Treatment Innovations

  2025cites this paper
• Evaluation of Endocrine Disruptome and VirtualToxLab for Predicting Per- and Polyfluoroalkyl Substances Binding to Nuclear Receptors

  2025cites this paper
• Mixtures of legacy and replacement perfluorosulphonic acids (PFSAs) demonstrate ratio-, concentration- and endpoint-dependent synergistic interactions in vitro.

  2024cites this paper
• Association between per- and polyfluoroalkyl substances and hyperuricemia: sex-specific analysis

  2024cites this paper
• Exploring Toxicity of Per- and Polyfluoroalkyl Substances (PFAS) Mixture Through ADMET and Toxicogenomic In Silico Analysis: Molecular Insights

  2024cites this paper
• The Impact of Early Life Exposure to Individual and Combined PFAS on Learning, Memory, and Bioaccumulation in C. elegans.

  2024cites this paper
• Evaluation of Approaches for Assessing PFAS Mixtures

  2023cites this paper
• Per- and polyfluoroalkyl substances (PFAS) in mixtures show additive effects on transcriptomic points of departure in human liver spheroids

  2023cites this paper
• Associations between maternal exposure to perfluoroalkylated substances (PFASs) and infant birth weight: a meta-analysis

  2023cites this paper
• Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes

  2023cites this paper
• Environmental impacts, exposure pathways, and health effects of PFOA and PFOS.

  2023cites this paper
• Legacy and emerging per- and polyfluoroalkyl substances (PFAS) regulate steroidogenesis in the male gonad.

  2023cites this paper
• In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.

  2022cites this paper
• Agonistic and potentiating effects of perfluoroalkyl substances (PFAS) on the Atlantic cod (Gadus morhua) peroxisome proliferator-activated receptors (Ppars).

  2022cites this paper
• Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat

  2022cites this paper
• Epidemiology Evidence for Health Effects of 150 per- and Polyfluoroalkyl Substances: A Systematic Evidence Map

  2022cites this paper
• Per- and polyfluoroalkyl substances exposure and its influence on the intestinal barrier: An overview on the advances.

  2022cites this paper
• Associations of single and multiple perfluoroalkyl substances exposure with folate among adolescents in NHANES 2007-2010.

  2022cites this paper
• The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.

  2021cites this paper
• Transcriptional Effects of Binary Combinations of PFAS in FaO Cells.

  2021cites this paper
• Per- and polyfluoroalkyl mixtures toxicity assessment “Proof-of-Concept” illustration for the hazard index approach

  2021cites this paper
• Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?

  2021cites this paper
• The relationship between maternal perfluoroalkylated substances exposure and low birth weight of offspring: a systematic review and meta-analysis

  2021cites this paper
• Predicting the Effects of Per- and Polyfluoroalkyl Substance Mixtures on Peroxisome Proliferator-Activated Receptor Alpha Activity in Vitro

  2021cites this paper
• Prenatal exposure of female mice to perfluorononanoic acid delays pubertal activation of the reproductive endocrine axis through enhanced hepatic FGF21 production.

  2020cites this paper
• Determinants of serum concentrations of perfluoroalkyl acids (PFAAs) in school children and the contribution of low-level PFAA-contaminated drinking water.

  2020cites this paper
• Perfluoroalkyl substances and anthropomorphic measures in children (ages 3-11 years), NHANES 2013-2014.

  2020cites this paper
• Associations between the serum levels of PFOS/PFOA and IgG N-glycosylation in adult or children.

  2020cites this paper
• Strategies for grouping per- and polyfluoroalkyl substances (PFAS) to protect human and environmental health.

  2020cites this paper
• Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells

  2020cites this paper
• Risk Assessment of Per‐ and Polyfluoroalkyl Substance Mixtures: A Relative Potency Factor Approach

  2020cites this paper
• Application of a Framework for Grouping and Mixtures Toxicity Assessment of PFAS: A Closer Examination of Dose-Additivity Approaches

  2020cites this paper
• Chemical Characterization of a Legacy Aqueous Film-Forming Foam Sample and Developmental Toxicity in Zebrafish (Danio rerio)

  2020cites this paper
• Per‐ and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

  2020cites this paper
• Per‐ and Polyfluoroalkyl Substances (PFAS) in Surface Water Near US Air Force Bases: Prioritizing Individual Chemicals and Mixtures for Toxicity Testing and Risk Assessment

  2020cites this paper
• Assessing the human health risks of per- and polyfluoroalkyl substances: A need for greater focus on their interactions as mixtures.

  2020cites this paper
• OP-TOXS200127 1..17

  2020cites this paper
• Strategies for grouping per- and poly fl uoroalkyl substances (PFAS) to protect human and environmental health CRITICAL REVIEW

  2020cites this paper
• Bayesian Factor Analysis for Inference on Interactions

  2019cites this paper
• Nuclear receptors are important targets of environmental disrupting compounds.

  2019cites this paper
• PFOS, PFOA, estrogen homeostasis, and birth size in Chinese infants.

  2019cites this paper
• Antioxidant defence system is responsible for the toxicological interactions of mixtures: A case study on PFOS and PFOA in Daphnia magna.

  2019cites this paper
• Hepatic carboxylesterases are differentially regulated in PPARα-null mice treated with perfluorooctanoic acid.

  2019cites this paper
• Environmental contaminants modulate the transcriptional activity of polar bear (Ursus maritimus) and human peroxisome proliferator-activated receptor alpha (PPARA)

  2019cites this paper
• Acute and chronic effects of perfluoroalkyl substance mixtures on larval American bullfrogs (Rana catesbeiana).

  2019cites this paper
• Low molecular weight PFAS alternatives (c-6) result in fewer cellular and behavioral alterations than long chain (c-8/c-9) PFASs in larval zebrafish

  2018cites this paper
• Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis

  2018cites this paper
• Perfluoroalkyl Substances in the Environment

  2018cites this paper
• Developmental Toxicity of Perfluorohexane Sulfonate (PFHxS) - Effects on the Immune and Thyroid Hormone Systems

  2018cites this paper
• Evaluation of a national data set for insights into sources, composition, and concentrations of per- and polyfluoroalkyl substances (PFASs) in U.S. drinking water.

  2018cites this paper
• Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

  2018cites this paper
• Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population.

  2018cites this paper
• Evaluation and Management Strategies for Per- and Polyfluoroalkyl Substances (PFASs) in Drinking Water Aquifers: Perspectives from Impacted U.S. Northeast Communities

  2018cites this paper
• A network biology-based approach to evaluating the effect of environmental contaminants on human interactome and diseases.

  2018cites this paper
• Circulating levels of perfluoroalkyl substances and left ventricular geometry of the heart in the elderly.

  2018cites this paper
• Circulating levels of perfluoroalkyl substances (PFASs) and carotid artery atherosclerosis

  2017cites this paper
• Toxic effects of perfluorinated compounds at human cellular level and on a model vertebrate.

  2017cites this paper
• Fatty acid metabolism in fish species as a biomarker for environmental monitoring.

  2016cites this paper
• Perfluorooctane sulfonate-induced insulin resistance is mediated by protein kinase B pathway.

  2016cites this paper
• Elevated levels of short carbon-chain PFCAs in breast milk among Korean women: Current status and potential challenges.

  2016cites this paper
• Metabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid (PFOA) and Agonists to Peroxisome Proliferator-Activated Receptors

  2015cites this paper
• Perfluorinated Compounds: An Overview

  2015cites this paper
• Per- and polyfluorinated substances (PFASs): Environmental challenges

  2015cites this paper